A detailed history of Global Alpha Capital Management Ltd. transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Global Alpha Capital Management Ltd. holds 536,450 shares of ANIP stock, worth $30.2 Million. This represents 2.08% of its overall portfolio holdings.

Number of Shares
536,450
Previous 526,950 1.8%
Holding current value
$30.2 Million
Previous $33.6 Million 4.63%
% of portfolio
2.08%
Previous 2.46%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$54.33 - $65.72 $516,135 - $624,340
9,500 Added 1.8%
536,450 $32 Million
Q2 2024

Aug 09, 2024

BUY
$58.53 - $68.82 $7.97 Million - $9.37 Million
136,200 Added 34.86%
526,950 $33.6 Million
Q1 2024

May 08, 2024

SELL
$54.2 - $69.69 $10.4 Million - $13.4 Million
-191,678 Reduced 32.91%
390,750 $27 Million
Q4 2023

Feb 09, 2024

BUY
$48.72 - $65.43 $2.77 Million - $3.72 Million
56,900 Added 10.83%
582,428 $32.1 Million
Q3 2023

Nov 13, 2023

BUY
$50.28 - $64.61 $3.63 Million - $4.66 Million
72,200 Added 15.93%
525,528 $30.5 Million
Q2 2023

Aug 10, 2023

SELL
$37.29 - $53.83 $359,214 - $518,544
-9,633 Reduced 2.08%
453,328 $24.4 Million
Q1 2023

May 09, 2023

BUY
$37.61 - $45.72 $505,102 - $614,019
13,430 Added 2.99%
462,961 $18.4 Million
Q4 2022

Feb 10, 2023

BUY
$31.9 - $41.95 $963,380 - $1.27 Million
30,200 Added 7.2%
449,531 $18.1 Million
Q3 2022

Nov 10, 2022

BUY
$29.83 - $38.01 $2.85 Million - $3.63 Million
95,600 Added 29.53%
419,331 $13.5 Million
Q2 2022

Aug 05, 2022

SELL
$23.09 - $33.46 $611,885 - $886,690
-26,500 Reduced 7.57%
323,731 $9.61 Million
Q1 2022

May 12, 2022

BUY
$26.91 - $47.15 $1.76 Million - $3.08 Million
65,400 Added 22.96%
350,231 $9.85 Million
Q4 2021

Feb 10, 2022

BUY
$32.97 - $56.85 $7.27 Million - $12.5 Million
220,399 Added 342.06%
284,831 $13.1 Million
Q3 2021

Nov 12, 2021

BUY
$26.48 - $35.99 $1.71 Million - $2.32 Million
64,432 New
64,432 $2.12 Million
Q4 2020

Feb 10, 2021

SELL
$23.69 - $31.47 $6.13 Million - $8.15 Million
-258,946 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$26.38 - $33.1 $429,994 - $539,530
-16,300 Reduced 5.92%
258,946 $7.31 Million
Q2 2020

Aug 13, 2020

BUY
$29.93 - $50.1 $1.72 Million - $2.88 Million
57,500 Added 26.41%
275,246 $8.9 Million
Q1 2020

May 13, 2020

BUY
$30.35 - $67.14 $1.46 Million - $3.22 Million
48,000 Added 28.28%
217,746 $8.87 Million
Q4 2019

Feb 12, 2020

BUY
$55.65 - $79.83 $1.26 Million - $1.81 Million
22,700 Added 15.44%
169,746 $10.5 Million
Q3 2019

Nov 13, 2019

BUY
$64.7 - $85.39 $297,620 - $392,794
4,600 Added 3.23%
147,046 $10.7 Million
Q2 2019

Aug 07, 2019

BUY
$67.77 - $82.2 $3.11 Million - $3.78 Million
45,935 Added 47.6%
142,446 $11.7 Million
Q1 2019

May 08, 2019

BUY
$45.83 - $70.54 $4.42 Million - $6.81 Million
96,511 New
96,511 $6.81 Million

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $982M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Global Alpha Capital Management Ltd. Portfolio

Follow Global Alpha Capital Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Alpha Capital Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Global Alpha Capital Management Ltd. with notifications on news.